418
Views
30
CrossRef citations to date
0
Altmetric
Original

Prospects for Treatment of Pediatric Vitreoretinal Diseases with Vascular Endothelial Growth Factor Inhibition

, , , &
Pages 70-76 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bilge Araz-Ersan, Nur Kir, Samuray Tuncer, Ozlem Aydinoglu-Candan, Dilbade Yildiz-Inec, Basri Akdogan, Baris Ekici, Atalay Demirel & Meral Ozmen. (2015) Preliminary Anatomical and Neurodevelopmental Outcomes of Intravitreal Bevacizumab As Adjunctive Treatment for Retinopathy of Prematurity. Current Eye Research 40:6, pages 585-591.
Read now

Articles from other publishers (29)

Hashem H. Ghoraba, Charles DeBoer & Darius M. Moshfeghi. (2023) Rapid Improvement in Lipid Maculopathy Following Faricimab Therapy in Recalcitrant Familial Exudative Vitreoretinopathy. Ophthalmic Surgery, Lasers and Imaging Retina 54:7, pages 426-428.
Crossref
Maciej Gawęcki & Andrzej Grzybowski. 2023. Retina Lasers in Ophthalmology. Retina Lasers in Ophthalmology 207 239 .
Licong Liang, Yiliu Yang, Shaochong Bu & Fang Lu. (2021) Case Report: A Case of Cotton-Wool Spots After Intravitreal Injection of Conbercept in an Infant With Incontinentia Pigmenti. Frontiers in Medicine 8.
Crossref
Jaimie Bryan, Reda Issa, Benjamin Bakall, Matthew Welch & J. Shepard Bryan. (2020) Retinal Manifestations of Incontinentia Pigmenti: A Case Series of 14 Patients Highlighting the Importance of Intravenous Fluorescein Angiography and the Benefits of Early Laser Photocoagulation. Journal of VitreoRetinal Diseases, pages 247412642096264.
Crossref
Shiro Nakao, Sachiko Nishina, Shin Tanaka, Tomoyo Yoshida, Tadashi Yokoi & Noriyuki Azuma. (2020) Early laser photocoagulation for extensive retinal avascularity in infants with incontinentia pigmenti. Japanese Journal of Ophthalmology 64:6, pages 613-620.
Crossref
Jie Peng, Tingyi Liang, Chunli Chen, Qi Zhang, Yu Xu, Jingjing Liu & Peiquan Zhao. (2020) Subretinal injection of ranibizumab in advanced pediatric vasoproliferative disorders with total retinal detachments. Graefe's Archive for Clinical and Experimental Ophthalmology 258:5, pages 1005-1012.
Crossref
Mehmet Yasin Teke, Kemal Tekin, Emre Aydemir & Fuat Yavrum. (2018) Mirror image of familial exudative vitreoretinopathy in identical twins. International Ophthalmology 39:4, pages 935-941.
Crossref
Linda A. Cernichiaro-Espinosa, Nimesh A. Patel, Mislen S. Bauer, Catherin I. Negron, Brenda Fallas, Alexander Pogrebniak & Audina M. Berrocal. (2019) Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome). Ophthalmic Surgery, Lasers and Imaging Retina 50:2.
Crossref
Yuanjun Li & Yedi Zhou. (2019) Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases. The Tohoku Journal of Experimental Medicine 247:2, pages 87-98.
Crossref
Natalie T. Huang, C. Gail Summers, Brandon K. McCafferty, Raymond G. AreauxJrJr, Dara D. Koozekanani & Sandra R. Montezuma. (2017) Management of Retinopathy in Incontinentia Pigmenti: A Systematic Review and Update. Journal of VitreoRetinal Diseases 2:1, pages 39-47.
Crossref
Mumin Hocaoglu, Murat Karacorlu, Isil Sayman Muslubas, Mehmet Giray Ersoz & Serra Arf. (2017) Anatomical and functional outcomes following vitrectomy for advanced familial exudative vitreoretinopathy: a single surgeon's experience. British Journal of Ophthalmology 101:7, pages 946-950.
Crossref
Alex J. Fay, Allison A. King, Joshua S. Shimony, Yanick J. Crow & Jan E. Brunstrom-Hernandez. (2017) Treatment of Leukoencephalopathy With Calcifications and Cysts With Bevacizumab. Pediatric Neurology 71, pages 56-59.
Crossref
Mary Ho, Wilson W. K. Yip, Vesta C. K. Chan & Alvin L. Young. (2017) SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD. RETINAL Cases & Brief Reports 11:4, pages 352-355.
Crossref
Matthew Denny, Sara J. Haug, Emmett T. Cunningham & J. Michael Jumper. (2016) FANCONI ANEMIA PRESENTING AS BILATERAL DIFFUSE RETINAL OCCLUSIVE VASCULOPATHY. RETINAL Cases & Brief Reports 10:2, pages 171-174.
Crossref
Amy S. Paller & Anthony J. Mancini. 2016. Hurwitz Clinical Pediatric Dermatology. Hurwitz Clinical Pediatric Dermatology 245 278.e8 .
Marcel N Menke, Carsten Framme, Mathias Nelle, Markus R Berger, Veit Sturm & Sebastian Wolf. (2015) Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease. BMC Ophthalmology 15:1.
Crossref
Avinash Mishra, Somesh Aggarwal, Sonali Shah, Puja Negi, Rekha Bharwada & Neha Desai. (2015) An interesting case of Coats' disease. Medical Journal Armed Forces India 71:4, pages 384-388.
Crossref
Christian C. Swinney, Dennis P. Han & Peter A. Karth. (2015) Incontinentia Pigmenti: A Comprehensive Review and Update. Ophthalmic Surgery, Lasers and Imaging Retina 46:6, pages 650-657.
Crossref
Akiko Mino, Yoshinori Mitamura, Takashi Katome, Kentaro Semba, Mariko Egawa & Takeshi Naito. (2015) Case of adult-onset Coats' disease with epiretinal membrane treated with 25-gauge pars plana vitrectomy. The Journal of Medical Investigation 62:1.2, pages 85-88.
Crossref
D F Gilmour. (2014) Familial exudative vitreoretinopathy and related retinopathies. Eye 29:1, pages 1-14.
Crossref
Matilde Immacolata Conte, Alessandra Pescatore, Mariateresa Paciolla, Elio Esposito, Maria Giuseppina Miano, Maria Brigida Lioi, Maeve A. McAleer, Giuliana Giardino, Claudio Pignata, Alan D. Irvine, Angela E. Scheuerle, Ghislaine Royer, Smail Hadj-Rabia, Christine Bodemer, Jean-Paul Bonnefont, Arnold Munnich, Asma Smahi, Julie Steffann, Francesca Fusco & Matilde Valeria Ursini. (2014) Insight into IKBKG / NEMO Locus: Report of New Mutations and Complex Genomic Rearrangements Leading to Incontinentia Pigmenti Disease . Human Mutation 35:2, pages 165-177.
Crossref
Parag K. Shah, Sandeep Bachu, Venkatapathy Narendran, Narendran Kalpana, Jeevamala David & Chakravarthi R. Srinivas. (2013) Intravitreal Bevacizumab for Incontinentia Pigmenti. Journal of Pediatric Ophthalmology & Strabismus.
Crossref
Khurram M. Chaudhary, Mihai Mititelu & Ronni M. Lieberman. (2013) An Evidence-Based Review of Vascular Endothelial Growth Factor Inhibition in Pediatric Retinal Diseases: Part 2. Coats’ Disease, Best Disease, and Uveitis With Childhood Neovascularization. Journal of Pediatric Ophthalmology & Strabismus 50:1, pages 11-19.
Crossref
Petra Meier & Peter Wiedemann. 2013. Retina. Retina 1933 1953 .
Filomena Fortinguerra, Antonio Clavenna & Maurizio Bonati. (2012) Ocular medicines in children: the regulatory situation related to clinical research. BMC Pediatrics 12:1.
Crossref
Charles C. Wykoff, Samuel K. Houston & Audina M. Berrocal. (2011) Anti-Vascular Endothelial Growth Factor Agents for Pediatric Retinal Diseases. International Ophthalmology Clinics 51:1, pages 185-199.
Crossref
Amy S. Paller & Anthony J. Mancini. 2011. Hurwitz Clinical Pediatric Dermatology. Hurwitz Clinical Pediatric Dermatology 234 267 .
S. Sacconi, S. Baillif-Gostoli & C. Desnuelle. (2010) Atteinte r?tinienne et myopathies g?n?tiques. Revue Neurologique 166:12, pages 998-1009.
Crossref
ANAND VINEKAR, NEWMAN SUND, POLLY QUIRAM & ANTONIO CAPONE. (2010) CHOROIDAL NEOVASCULAR MEMBRANE IN PERSISTENT FETAL VASCULATURE SYNDROME MANAGED WITH INTRAVITREAL PEGAPTANIB SODIUM IN AN INFANT. Retina 30:4, pages S41-S44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.